Empowering clinicians with AI medical technologies that solve real challenges.

About Us

Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery.

Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. To learn more about Keya Medical, follow us on LinkedInTwitter, and Facebook.

Triple certification of CR FFR Analysis – DEEPVESSEL FFR


January 2020

DeepVessel® FFR


August 2018

DeepVessel® FFR


April 2022

DeepVessel® FFR

Comprehensive R&D Pipeline Solution Suites

Keya Medical Comprehensive Solutions

Keya Medical is developing a comprehensive R&D pipeline to deliver clinical value throughout the patient care process. The product candidates in our pipeline will be designed for use in early screening, diagnosis, treatment, and post-treatment followup.

By the Numbers


Collaboration Partners

Registered Patents



Keya Medical is founded


Keya Medical establishes the first AI diagnostic laboratory


DeepVessel FFR enters the CFDA Special Approval Channel for Innovative Medical Devices

Keya Medical receives ISO 13485 certification

DeepVessel FFR receives CE Mark


Keya Medical is selected to the Top 100 Medical Companies of the Future list by VCBeat Research


DeepVessel FFR becomes the first Class-III AI medical device approved for clinical use by the Chinese National Medical Products Administration

$15 million in strategic funding

$20 million in Series B+ funding

$30 million in Series C funding

$46 million in Series D funding


DeepVessel FFR demonstrates an accuracy of 92% in a single-center retrospective study conducted by researchers at Fuwai Hospital


ADAPT clinical trial is completed

DeepVessel FFR received FDA clearance


The TARGET Randomized Trial presented at Late-breaking science at ACC 2023


DEEPVESSEL FFR joins Calantic (Bayer) AI platrform